← FDA Drug Approvals (Drugs@FDA)
PALYNZIQ
BLA · Biologics License Application · Sponsor: BIOMARIN PHARM · Approved 2018-05-24
Drug application
- FDA Application #
BLA761079- Application type
- Biologics License Application
- Brand name
- PALYNZIQ
- Generic name
- PEGVALIASE-PQPZ
- Active ingredients
- PEGVALIASE-PQPZ
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- BIOMARIN PHARM
- Manufacturer
- BioMarin Pharmaceutical Inc.
- First approval
- 2018-05-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown